Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(dysmenorrhea)
6,726 results
  • Exercise for dysmenorrhoea. [Review]
    Cochrane Database Syst Rev 2019; 9:CD004142Armour M, Ee CC, … Delshad E
  • CONCLUSIONS: The current low-quality evidence suggests that exercise, performed for about 45 to 60 minutes each time, three times per week or more, regardless of intensity, may provide a clinically significant reduction in menstrual pain intensity of around 25 mm on a 100 mm VAS. All studies used exercise regularly throughout the month, with some studies asking women not to exercise during menstruation. Given the overall health benefits of exercise, and the relatively low risk of side effects reported in the general population, women may consider using exercise, either alone or in conjunction with other modalities, such as NSAIDs, to manage menstrual pain. It is unclear if the benefits of exercise persist after regular exercise has stopped or if they are similar in women over the age of 25. Further research is required, using validated outcome measures, adequate blinding and suitable comparator groups reflecting current best practice or accounting for the extra attention given during exercise.
  • The effect of bee prepolis on primary dysmenorrhea: a randomized clinical trial. [Journal Article]
    Obstet Gynecol Sci 2019; 62(5):352-356Jenabi E, Fereidooni B, … Khazaei S
  • CONCLUSIONS: Our study showed that the use of bee propolis for two months compared with placebo reduced primary dysmenorrhea during the first and second months after use, with no adverse effects. Therefore, it could be used as an alternative to nonsteroidal anti-inflammatory drugs for relief of primary dysmenorrhea.
  • Polycystic ovarian morphology is associated with primary dysmenorrhea in young Korean women. [Journal Article]
    Obstet Gynecol Sci 2019; 62(5):329-334Jeong JY, Kim MK, … Lee BS
  • CONCLUSIONS: Our study shows that PCOM may have a correlation with the severity of primary dysmenorrhea. Since PCOM may play a role in the development of menstrual pain, patients with PCOM should be under active surveillance with resources for prompt pain management readily available. It may also be necessary to further investigate the molecular mechanisms of pain development in primary dysmenorrhea.
  • Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding. [Review]
    Cochrane Database Syst Rev 2019; 9:CD000400Bofill Rodriguez M, Lethaby A, Farquhar C
  • CONCLUSIONS: NSAIDs reduce HMB when compared with placebo, but are less effective than tranexamic acid, danazol or LNG IUS. However, adverse events are more severe with danazol therapy. In the limited number of small studies suitable for evaluation, there was no clear evidence of a difference in efficacy between NSAIDs and other medical treatments such as oral luteal progestogen, ethamsylate, OCP or the older progesterone-releasing intrauterine system.
New Search Next